JCO yields 25.16% · MRK yields 2.76%● Live data
📍 JCO pulled ahead of the other in Year 1
Combined, JCO + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JCO + MRK for your $10,000?
Nuveen Credit Opportunities 2022 Target Term Fund is a closed ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors, LLC and Symphony Asset Management. It invests in fixed income markets of the United States. The fund primarily invests in corporate debt securities including bonds and senior loans. It invests in investment grade fixed income securities rated BBB- or higher by S&P with a maturity date on June 1, 2022. The fund employs a fundamental analysis with bottom-up stock picking approach while focusing on factors such as sector dynamics, company business models and asset quality and analysis of the relative value to create its portfolio. Nuveen Credit Opportunities 2022 Target Term Fund was formed on September 28, 2016 and is domiciled in the United States.
Full JCO Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.